Allianz Asset Management GmbH - PERNIX THERAPEUTICS HLDGS IN ownership

Quarter-by-quarter ownership
Allianz Asset Management GmbH ownership history of PERNIX THERAPEUTICS HLDGS IN
ValueSharesWeighting
Q2 2015$3,071,000
-74.0%
518,804
-53.1%
0.00%
-78.6%
Q1 2015$11,834,000
+130.9%
1,106,994
+102.8%
0.01%
+133.3%
Q4 2014$5,125,000
+20.9%
545,839
-1.1%
0.01%
+20.0%
Q3 2014$4,239,000
-16.1%
551,900
-1.9%
0.01%
-16.7%
Q2 2014$5,053,000562,7460.01%
Other shareholders
PERNIX THERAPEUTICS HLDGS IN shareholders Q3 2023
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 2,484,649$7,330,0008.59%
Avoro Capital Advisors LLC 5,144,916$15,178,0005.23%
Broadfin Capital, LLC 6,090,829$17,968,0001.10%
Aisling Capital LLC 2,010,000$5,930,0001.02%
Healthcare Value Capital, LLC 150,000$443,0000.73%
ACUTA CAPITAL PARTNERS, LLC 434,300$1,281,0000.61%
WALL STREET ASSOCIATES 696,300$2,054,0000.58%
SEARLE & CO. 172,500$500,0000.48%
Elk Creek Partners, LLC 2,253,667$6,648,0000.47%
KOPP INVESTMENT ADVISORS LLC 315,293$931,0000.46%
View complete list of PERNIX THERAPEUTICS HLDGS IN shareholders